Delivery Order SPE2DB22D3004-SPE2DB24FRM76

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is valued at $8,139.82 and has a completion date of September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $1,029.66 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,749,615 units of the drug Ondansetron HCl 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,247.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. for the supply of 4,565,469,507 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,751,394 units of Ondansetron ODT 4 mg tablets. The contract has a firm fixed price of $5,976.49 and a completion date of September 11, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
The U.S. Defense Logistics Agency (DLA) awarded a $4,269.75 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565536168 Ondansetron ODT 4 mg Tablets in 30-count packages. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,214,940 units of the drug ondansetron ODT 4 mg tablet. The delivery order, valued at $1,883.31, is a firm-fixed-price contract with a completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support...
This is a $23,129.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,218,533 units of Ondansetron ODT 4 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a wide range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The $7,954.22 firm fixed-price contract has an ultimate completion date of April 11, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRM76
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $7,854.60 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,502,316 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 20, 2024 and does not utilize a set-aside designation.

Generated 11/18/24, 9:34 AM